<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Laragione T</submitter><funding>NIAMS</funding><funding>NIAMS NIH HHS</funding><funding>Icahn School of Medicine at Mount Sinai</funding><pagination>110158</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11225809</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(6)</volume><pubmed_abstract>Receptor tyrosine kinases (RTKs) have an important role in arthritis severity and in models of rheumatoid arthritis (RA), but their regulation is not fully understood. The dual specificity phosphatase 6 (DUSP6) has been implicated in the regulation of RTK signaling, but never in the context of arthritis and autoimmunity. We used the KRN serum-induced arthritis (KSIA) model of RA and showed that DUSP6&lt;sup>-/-&lt;/sup> mice were protected and had a 50% lower maximum arthritis score (&lt;i>p&lt;/i> = 0.006) and reduced joint damage than C57BL/6 DUSP6+/+ controls. Serum levels of interleukin (IL) 10 were significantly increased (>2-fold), and IL6 decreased in DUSP6&lt;sup>-/-&lt;/sup> mice. DUSP6&lt;sup>-/-&lt;/sup> mice had increased numbers of IL10+ cells including Tr1 regulatory cells (&lt;i>p&lt;/i> &lt; 0.01). Introdu</pubmed_abstract><journal>iScience</journal><pubmed_title>DUSP6 deletion protects mice and reduces disease severity in autoimmune arthritis.</pubmed_title><pmcid>PMC11225809</pmcid><funding_grant_id>R01 AR073165</funding_grant_id><pubmed_authors>Rice N</pubmed_authors><pubmed_authors>Laragione T</pubmed_authors><pubmed_authors>Harris C</pubmed_authors><pubmed_authors>Gulko PS</pubmed_authors></additional><is_claimable>false</is_claimable><name>DUSP6 deletion protects mice and reduces disease severity in autoimmune arthritis.</name><description>Receptor tyrosine kinases (RTKs) have an important role in arthritis severity and in models of rheumatoid arthritis (RA), but their regulation is not fully understood. The dual specificity phosphatase 6 (DUSP6) has been implicated in the regulation of RTK signaling, but never in the context of arthritis and autoimmunity. We used the KRN serum-induced arthritis (KSIA) model of RA and showed that DUSP6&lt;sup>-/-&lt;/sup> mice were protected and had a 50% lower maximum arthritis score (&lt;i>p&lt;/i> = 0.006) and reduced joint damage than C57BL/6 DUSP6+/+ controls. Serum levels of interleukin (IL) 10 were significantly increased (>2-fold), and IL6 decreased in DUSP6&lt;sup>-/-&lt;/sup> mice. DUSP6&lt;sup>-/-&lt;/sup> mice had increased numbers of IL10+ cells including Tr1 regulatory cells (&lt;i>p&lt;/i> &lt; 0.01). Introdu</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-05-29T09:57:33.92Z</modification><creation>2025-04-04T12:22:12.491Z</creation></dates><accession>S-EPMC11225809</accession><cross_references><pubmed>38974475</pubmed><doi>10.1016/j.isci.2024.110158</doi></cross_references></HashMap>